Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
2(14%)
Results Posted
20%(2 trials)

Phase Distribution

Ph phase_2
3
21%
Ph phase_3
2
14%
Ph phase_4
2
14%
Ph not_applicable
6
43%
Ph phase_1
1
7%

Phase Distribution

1

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
1(7.1%)
Phase 2Efficacy & side effects
3(21.4%)
Phase 3Large-scale testing
2(14.3%)
Phase 4Post-market surveillance
2(14.3%)
N/ANon-phased studies
6(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(10)
Other(2)

Detailed Status

Completed10
unknown2
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.1%)
Phase 23 (21.4%)
Phase 32 (14.3%)
Phase 42 (14.3%)
N/A6 (42.9%)

Trials by Status

recruiting17%
unknown214%
active_not_recruiting17%
completed1071%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT07660081Not Applicable

Effects of Acetyl L-Carnitine Supplementation on Clinical, Metabolic and Inflammatory Symptoms in Obese, Diabetic, Postmenopausal Women With Osteoarthritis

Active Not Recruiting
NCT06126315Phase 2

Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS

Recruiting
NCT05601479Phase 2

Preventive Effect of Acetyl-L-carnitine on Oxaliplatin-induced Peripheral Neuropathy

Unknown
NCT01695317Phase 4

Effect of Acetyl-L-carnitine in Migraine

Completed
NCT00050271Not Applicable

Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy

Completed
NCT02955706Phase 4

Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease

Completed
NCT00592488Phase 1

Acetyl-L-Carnitine in the Treatment of Septic Shock

Completed
NCT02141035Phase 2

Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome

Completed
NCT01921868Not Applicable

An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia

Unknown
NCT02173132Phase 3

Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy

Completed
NCT01909557Phase 3

Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.

Completed
NCT01223768Not Applicable

Acetyl-L-Carnitine In Severe Hepatic Encephalopathy

Completed
NCT01223729Not Applicable

Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy

Completed
NCT01223742Not Applicable

Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14